US recommends ‘pause’ for J&J vaccine over clot reports
The Johnson & Johnson COVID-19 vaccine sits on a table at a pop-up vaccination site the Albanian Islamic Cultural Center, in the Staten Island borough of New York. (AP file photo/Mary Altaffer)
WASHINGTON – The U.S. is recommending a “pause” in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots.
In a joint statement Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration said they were investigating clots in six women that occurred six to 13 days after vaccination. The clots were observed in the sinuses of the brain along with reduced platelet counts – making the usual treatment for blood clots, the blood thinner heparin, potentially “dangerous.”
She has had to endure not just a public health crisis and a hostile state legislature, but friends who have passed from the virus, armed aggression in the state Capitol and threats against her life. She’s also had to coordinate a disaster response to a faulty dam burst, all while doing all of this, in a devastated Michigan community, Psaki continued. So we feel she’s shown some serious grit, fight and resolve. We’re going to continue to work with her on how we can help address the uptick in her state and help deploy the resources we have available.